Skip to main content

and
  1. Article

    Open Access

    Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation

    Activating mutations in KRAS frequently occur in colorectal cancer (CRC) patients, leading to resistance to EGFR-targeted therapies.

    Theodosia Charitou, Sriganesh Srihari, Miriam A. Lynn in British Journal of Cancer (2019)